Patients Are at the Forefront of Everything We Do

With a vision of creating a healthier tomorrow for patients with kidney and cardiorenal diseases, we are steadfast in our approach to translating novel biologic insights into targeted therapies for patients where few to no treatment options exist. To this end, we are advancing a pipeline of promising candidates with the potential to provide life-changing benefits.

We Are Committed to Our Patients

“All of us at Ardelyx are sincerely grateful to the patients who participate in our clinical studies, as well as their families and caregivers who are with them along their journey. Everyone here at Ardelyx is passionately committed to serving our patients in the best way possible, and it’s because of each patient’s individual contribution that we are able to do the work necessary to bring forward important new medicines.”

Mike Raab

President & Chief Executive Officer

Advocacy Resources